| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $86K | -56.7% |
| Cost of Revenue | $93K | -41.8% |
| Gross Profit | -$7K | -119.3% |
| R&D Expense | $6.2M | +8.1% |
| SG&A Expense | $3.6M | +2.1% |
| Operating Income | -$11.1M | -6.9% |
| Net Income | -$10.4M | -4.7% |
| EPS (Basic) | -$1.28 | +20.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $15.8M | +86.9% |
| Accounts Receivable | $692 | -99.0% |
| Inventory | $96K | +18.4% |
| Current Assets | $16.3M | +78.9% |
| Total Assets | $19.8M | +61.9% |
| Current Liabilities | $561K | -39.8% |
| Total Liabilities | $2.0M | -9.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.7M | -22.6% |
| Capital Expenditures | $197K | -18.1% |
| Investing Cash Flow | -$506K | +3.2% |
| Financing Cash Flow | $16.6M | +7783.7% |
| Free Cash Flow | -$8.9M | -21.3% |
| Stockholders' Equity |
| $17.9M |
| +77.5% |